Private Equity

With a strong debut on the Hong Kong Stock Exchange, USAS Building System highlights growing investor faith in prefabricated industrial construction.

The nation's largest portable toilet provider files for pre-packaged bankruptcy, securing $1.1B to ensure operations continue without disruption.

Everybody Loves Languages' CEO and CFO are taking the company private, raising questions about minority shareholder value and the firm's future strategy.

Tevogen's Dr. Ryan Saadi donates over $88,000 in company stock to a UN-recognized charity, bolstering educational programs for underserved children.

Global marine supplier Wrist Group buys century-old Delaware Ship Supply, consolidating its power on the U.S. East Coast and ushering in a digital future.

A major acquisition turned sour, a 25% stock crash, and now a class action lawsuit. Inside Perrigo's costly infant formula venture and what it means.

After a series of operational disasters and market pressures, materials giant Ascend emerges from Chapter 11 with a clean slate and a plan to dominate.

Fourth-generation farmer John Melo brings large-scale operational expertise to the Dairy Council, poised to shape California's dairy sustainability and health initiatives.

Brock Purdy, CJ Stroud, and dozens of NFL stars are using their platform to demand U.S. intervention in Nigeria's escalating religious persecution crisis.

Charlesbank's strategic funding validates HBox’s 'clinic within a clinic' model, aiming to revolutionize care for high-risk chronic conditions.

Mirum raises over a quarter-billion dollars to acquire Bluejay Therapeutics, targeting a high-potential liver disease drug and signaling major growth.

In a landmark deal, BioMarin acquires Amicus Therapeutics, gaining high-growth drugs and reshaping the landscape for patients with rare genetic disorders.

A landmark executive order reclassifying cannabis is set to unleash a wave of biopharma innovation, validating science-first firms like Avicanna.

In a high-level diplomatic dinner, Argentina's ambassador showcased President Milei's sweeping reforms, signaling a new chapter for UK investment.

Facing a cash crunch, the Danish innovator seeks funds to survive, betting its future on a next-gen biotech solution to global water challenges.

The CEO of Genenta Science now owns 10% of the company, all bought on the open market. What does this bold insider move signal for its cancer therapy?

Nova Minerals is raising $20M to advance its Estelle Project, a key Alaskan site for gold and the strategically vital mineral antimony amid global supply woes.

Following PwC's resignation, the private credit firm's move to MNP signals a new chapter in its financial governance as it streamlines operations.

Titan Mining's new funding aims to end a 70-year U.S. graphite production gap, a critical move for the nation's EV and energy independence goals.

With a massive capital raise and rapid microreactor progress, NANO Nuclear is positioning itself to power the AI boom and lead a new nuclear renaissance.